0.1300CAD-7.14%Mkt Cap: 24.40M CADP/E: —Last update: 2026-05-26
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical Syst…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
53.79BSEKP/E 100.1
52.47BSEKP/E 22.3
51.50BDKKP/E 21.8
50.54BUSDP/E 47.4
38.75BEURP/E 18.3
Indicators:|
Key Statistics
Company
Market Cap24.40M CAD
Enterprise Value27.09M CAD
Revenue (TTM)179.93K CAD
Gross Profit179.93K CAD
Net Income (TTM)-3.20M CAD
Revenue/Share0.0010 CAD
Last Price0.1300 CAD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryCA
SectorHealthcare
IndustryMedical Devices
ISINCA92281P2008
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-7.97
EV/Revenue150.57
P/S151.23
P/B-5.18
EPS (TTM)-0.02
EPS (Forward)—
52W Range
0.080045% of range0.1900
52W High0.1900 CAD
52W Low0.0800 CAD
Profitability
Gross Margin100.00%
Oper. Margin-17160.90%
EBITDA Margin0.00%
Profit Margin-1778.62%
ROE77.74%
ROA-677.90%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.55M CAD
CapEx (TTM)—
FCF Margin-883.54%
FCF Yield-6.52%
Net Debt2.56M CAD
Net Debt/EBITDA-0.75
Balance Sheet
Debt/Equity-0.63
Current Ratio0.08
Quick Ratio0.04
Book Value/Sh-0.0280 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateDec 7, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.187.66M
Float166.83M
Insiders1.46%
Institutions0.00%
Short Interest
Short Ratio1.1d
Short % Out.0.09%
Shares Short131.53K
Short (prev mo.)151.22K
Technical
SMA 500.1232 (+5.5%)
SMA 2000.1153 (+12.7%)
Beta-0.04
S&P 52W Chg28.31%
Avg Vol (30d)199.69K
Avg Vol (10d)152.76K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—